Sandra A O'Toole Selected Research

Sandra A O'Toole Research Topics

Disease

35	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2009
32	Neoplasms (Cancer) 02/2019 - 09/2009
8	Carcinoma (Carcinomatosis) 01/2018 - 01/2009
8	Neoplasm Metastasis (Metastasis) 12/2016 - 10/2009
5	Carcinogenesis 01/2019 - 01/2011
5	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2017 - 10/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016 - 09/2013
4	Melanoma (Melanoma, Malignant) 10/2016 - 04/2014
3	Triple Negative Breast Neoplasms 01/2020 - 06/2013
3	Ductal Carcinoma 03/2017 - 06/2011
2	Hypoxia (Hypoxemia) 04/2011 - 02/2011
1	Lobular Carcinoma 02/2022
1	Breast Cyst 06/2020
1	Hypertension (High Blood Pressure) 03/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2017
1	Lymphatic Metastasis 01/2016
1	Paralysis (Palsy) 01/2016
1	Lung Neoplasms (Lung Cancer) 10/2013
1	Sarcoma (Soft Tissue Sarcoma) 10/2013
1	Adenocarcinoma 10/2013
1	Adenocarcinoma of Lung 04/2013
1	Pancreatic Cyst 01/2013

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2009
11	Proteins (Proteins, Gene)FDA Link 06/2020 - 11/2010
7	Phenobarbital (Luminal)FDA Link 10/2017 - 10/2009
6	Hormones (Hormone)IBA 11/2020 - 09/2009
6	Estrogen ReceptorsIBA 10/2017 - 10/2009
5	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 01/2011
5	ErbB Receptors (EGF Receptor)IBA 04/2015 - 10/2009
4	LigandsIBA 01/2021 - 06/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 10/2017 - 10/2009
4	Messenger RNA (mRNA)IBA 12/2015 - 03/2010
3	Androgen Receptors (Androgen Receptor)IBA 06/2020 - 01/2016
3	ParaffinIBA 02/2019 - 04/2014
3	Tyrosine (L-Tyrosine)FDA Link 11/2013 - 11/2010
2	B7-H1 AntigenIBA 11/2020 - 07/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 12/2015
2	CytokinesIBA 03/2017 - 02/2013
2	Interleukin-6 (Interleukin 6)IBA 03/2017 - 02/2013
2	src-Family KinasesIBA 12/2016 - 11/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2016 - 10/2013
2	Formaldehyde (Formol)FDA Link 10/2014 - 04/2014
2	Monoclonal AntibodiesIBA 08/2014 - 06/2011
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2010 - 01/2010
1	MucinsIBA 02/2022
1	atezolizumabIBA 01/2021
1	Apolipoproteins D (Apo D)IBA 06/2020
1	AndrogensIBA 06/2020
1	Inhibitor of Differentiation Protein 1IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Biological ProductsIBA 01/2019
1	CSK Tyrosine-Protein KinaseIBA 01/2019
1	Histone MethyltransferasesIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Keratin-14 (Keratin 14)IBA 01/2018
1	Estrogen Receptor alphaIBA 01/2018
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2018
1	CathepsinsIBA 12/2017
1	N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA 12/2017
1	Cathepsin BIBA 12/2017
1	Cysteine (L-Cysteine)FDA Link 12/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2017
1	Cystatin AIBA 12/2017
1	Indicators and Reagents (Reagents)IBA 10/2017
1	Transcription Factors (Transcription Factor)IBA 10/2017
1	Angiotensin Receptor AntagonistsIBA 03/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2017
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 03/2017
1	Complement System Proteins (Complement)IBA 03/2017
1	Losartan (Cozaar)FDA LinkGeneric 03/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2017
1	CarcinogensIBA 03/2017
1	bioplexIBA 03/2017
1	Dasatinib (BMS 354825)FDA Link 12/2016
1	Melanoma-Specific AntigensIBA 10/2016
1	Immune Checkpoint InhibitorsIBA 10/2016
1	Tyrosine Kinase InhibitorsIBA 04/2015
1	Estrogens (Estrogen)FDA Link 11/2013
1	Tamoxifen FDA LinkGeneric 11/2013
1	Discoidin Domain Receptor 2IBA 10/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2013
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2013
1	CateninsIBA 07/2013
1	Activating Transcription Factor 3IBA 07/2013
1	Progesterone FDA LinkGeneric 06/2013
1	HhAntag691IBA 03/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2013
1	Carbonic Anhydrase IXIBA 04/2011
1	UbiquitinIBA 02/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 02/2011
1	Ligases (Synthetase)IBA 02/2011
1	human ERBB2 proteinIBA 02/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011

Therapy/Procedure

16	Therapeutics 11/2020 - 01/2009
2	Radiotherapy 01/2018 - 12/2015
1	Immunotherapy 11/2020
1	Precision Medicine 04/2015
1	Drug Therapy (Chemotherapy) 01/2011